Combined pan-RAF and MEK inhibition overcomes multiple resistance mechanisms to selective RAF inhibitors

類似資料

• Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
  著者:: Atefi, Mohammad, 等
  出版事項: (2015)
• A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition
  著者:: Whittaker, Steven R., 等
  出版事項: (2013)
• C-RAF mutations confer resistance to RAF inhibitors
  著者:: Antony, Rajee, 等
  出版事項: (2013)
• MEK1 mutations confer resistance to MEK and B-RAF inhibition
  著者:: Emery, Caroline M., 等
  出版事項: (2009)
• Anti-tumor activities of the new oral pan-RAF inhibitor, TAK-580, used as monotherapy or in combination with novel agents in multiple myeloma
  著者:: Suzuki, Rikio, 等
  出版事項: (2020)